We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings

    Introduction

    Hereditary transthyretin amyloidosis (ATTRv, also referred to as hATTR; ORPHA 271861) and wild-type ATTR amyloidosis (ATTRwt; ORPHA...

    Mathew S. Maurer, Prem Soman, ... Victoria Sanjurjo in Advances in Therapy
    Article 04 June 2024
  2. Gastric Amyloidosis—a Case Report

    Amyloids are abnormal misfolded proteins that are resistant to degradation. Due to defective metabolism, they may be deposited in various organs...

    Golam Kibria, Musab Khalil, ... Tuhin Akhter in SN Comprehensive Clinical Medicine
    Article 15 May 2024
  3. Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey

    Introduction

    Transthyretin amyloidosis (ATTR amyloidosis) is primarily associated with a cardiac or neurologic phenotype, but a mixed phenotype is...

    Juan González-Moreno, Angela Dispenzieri, ... Jeffrey Ralph in Cardiology and Therapy
    Article Open access 20 December 2023
  4. AA Amyloidosis: A Contemporary View

    Purpose of Review

    Amyloid A (AA) amyloidosis is an organ- or life-threatening complication of chronic inflammatory disorders. Here, we review the...

    Safak Mirioglu, Omer Uludag, ... Ahmet Gul in Current Rheumatology Reports
    Article Open access 03 April 2024
  5. Cardiac Amyloidosis Diagnosis and Treatment

    Cardiac amyloidosis (CA) is caused by the accumulation of amyloid fibrils in the extracellular space of the myocardium, with clinical manifestations...

    Michele Emdin, Giuseppe Vergaro, ... Marianna Fontana
    Book 2024
  6. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group

    Systemic immunoglobulin light chain (AL) amyloidosis is a heterogeneous rare disease driven by a destructive monoclonal gammopathy and typified by...

    Michelle L. Mauermann, John O. Clarke, ... James Signorovitch in Advances in Therapy
    Article Open access 02 September 2023
  7. Localized amyloidosis of the ureter: a case report

    Background

    Amyloidosis is a collection of disorders characterized by the extracellular deposition of amyloid, a specialized fibrous protein, in...

    Shuntaro Aoki, Takashi Kawahara, ... Junichi Ohta in Journal of Medical Case Reports
    Article Open access 08 October 2023
  8. Outcomes of patients with cardiac amyloidosis undergoing percutaneous left atrial appendage occlusion

    Background

    There is limited data on the safety and efficacy of left atrial appendage occlusion (LAAO) devices in patients with cardiac amyloidosis. We...

    Siddharth Agarwal, Sukriti Banthiya, ... Zain Ul Abideen Asad in Journal of Interventional Cardiac Electrophysiology
    Article 01 June 2024
  9. Surgical strategies for localized colorectal amyloidosis

    Background

    Localized colorectal amyloidosis has a good prognosis, but cases involving bleeding or perforation may require surgery. However, there are...

    Shunya Tahara, Mohei Kohyama, ... Masaru Sasaki in Surgical Case Reports
    Article Open access 27 April 2023
  10. Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review

    Background

    Hereditary and wild-type transthyretin-mediated (ATTRv and ATTRwt) amyloidoses result from the misfolding of transthyretin and aggregation...

    Emre Aldinc, Courtney Campbell, ... Dafang Zhang in BMC Musculoskeletal Disorders
    Article Open access 22 September 2023
  11. Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability

    Hereditary transthyretin-related amyloidosis (ATTRv amyloidosis) is a rare and progressively debilitating disease characterized by the deposition of...

    Estefânia Carvalho, Andreia Dias, ... Carolina Lemos in Journal of Neurology
    Article Open access 22 June 2024
  12. Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis

    Cardiac amyloidosis is a refractory cardiomyopathy with a poor prognosis and lacks effective treatments. N-terminal pro-brain natriuretic peptide...

    Ye Zhu, Haitao Yuan, Huiting Qu in Heart and Vessels
    Article 05 April 2024
  13. Preoperative diagnosis and safe surgical approach in gallbladder amyloidosis: a case report

    Background

    Preoperative diagnosis of gallbladder amyloidosis is usually difficult. In our case, the patient exhibited gallbladder dyskinesia, which...

    Makoto Shinohara, Masakazu Hashimoto, ... Hideki Nakahara in Surgical Case Reports
    Article Open access 18 April 2024
  14. Amyloidosis and Fabry Disease A Clinical Guide

    This book presents a multispecialty and multidisciplinary approach on Amyloidosis and Fabry disease. These two “rare” diseases are underdiagnosed and...

    Diane Xavier de Ávila, Humberto Villacorta Junior
    Book 2023
  15. A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee

    We retrospectively gathered data of 21 patients (13 male and 8 female; median age 65 years) diagnosed with immunoglobulin M (IgM)-related light-chain...

    Shin-ichi Fuchida, Mizuki Ogura, ... Chihiro Shimazaki in International Journal of Hematology
    Article 29 July 2023
  16. Amyloidosis: a case series and review of the literature

    Background

    Systemic amyloidosis is group of disorders characterized by the accumulation of insoluble proteins in tissues. The most common form of...

    Justin B. Senecal, Romel Abou-Akl, ... Indryas Woldie in Journal of Medical Case Reports
    Article Open access 21 April 2023
  17. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

    Silencing the transthyretin ( TTR ) gene is an effective strategy in the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis. Vutrisiran...

    Tina Nie, Young-A Heo, Matt Shirley in Drugs
    Article 20 September 2023
  18. Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis

    Serum immunofixation electrophoresis (IFE) is often performed for screening monoclonal proteins (M proteins) in immunoglobulin light-chain...

    Yawara Kawano, Nao Nishimura, Jun-Ichirou Yasunaga in International Journal of Hematology
    Article 13 May 2024
  19. A case of bilateral amyloidosis localized to extraocular muscles mimicking thyroid eye disease

    Background

    Amyloidosis is a rare condition characterized by the abnormal deposition of amyloid proteins in various tissues and organs. While systemic...

    Natsuyo Yoshida-Hata, Masashi Mimura, ... Tomoyuki Kashima in BMC Ophthalmology
    Article Open access 26 January 2024
  20. Tracheobronchial Amyloidosis: A Case Report

    We report a case of an incidentally found tracheobronchial amyloidosis in an asymptomatic patient. A elderly male was admitted to the hospital for an...

    Mai Al Khatalin, Abdallah Dalal, ... Onur Yildirim in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 08 December 2022
Did you find what you were looking for? Share feedback.